Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 7 (2010), Issue 2 (February)

1. Interfractional uncertainty in the treatment of pancreatic cancer with radiation.
   Int J Radiat Oncol Biol Phys, 76(2): 603-7. [Abstract] [Full-text]
2. Use of respiratory-correlated four-dimensional computed tomography to determine acceptable treatment margins for locally advanced pancreatic adenocarcinoma.
   Int J Radiat Oncol Biol Phys, 76(2): 597-602. [Abstract] [Full-text]
3. E-cadherin-160 C/A promoter polymorphism and risk of pancreatic carcinoma in Chinese population.
   Cancer Genet Cytogenet, 197(1): 25-31. [Abstract] [Full-text]
4. Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma?
   Cancer, 116(3): 723-33. [Abstract] [Full-text]
5. Comparison of different tissue sampling methods for protein extraction from formalin-fixed and paraffin-embedded tissue specimens.
   Exp Mol Pathol, 88(1): 190-6. [Abstract] [Full-text]
6. CIP4 is a new ArgBP2 interacting protein that modulates the ArgBP2 mediated control of WAVE1 phosphorylation and cancer cell migration.
   Cancer Lett, 288(1): 116-23. [Abstract] [Full-text]
7. Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression.
   Cancer Invest, 28(2): 166-71. [Abstract] [Full-text]
8. Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.
   J Clin Invest, 120(2): 508-20. [Abstract] [Full-text]
9. Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-kappaB signalling pathways in human pancreatic adenocarcinoma cells.
   Br J Cancer, 102(3): 583-93. [Abstract] [Full-text]
10. Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer.
    Br J Cancer, 102(3): 577-82. [Abstract] [Full-text]
11. Phase II clinical trial of paclitaxel loaded polymeric micelle in patients with advanced pancreatic cancer.
    Cancer Invest, 28(2): 186-94. [Abstract] [Full-text]
12. Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in mice.
    Oncogene, 29(5): 674-86. [Abstract] [Full-text]
13. RBBP9: a tumor-associated serine hydrolase activity required for pancreatic neoplasia.
    Proc Natl Acad Sci U S A, 107(5): 2189-94. [Abstract] [Full-text]
14. Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.
    Int J Radiat Oncol Biol Phys, 76(3): 839-44. [Abstract] [Full-text]
15. External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study.
    Int J Radiat Oncol Biol Phys, 76(3): 831-8. [Abstract] [Full-text]

© 2004-2010 Pancreatic Cancer Research Today. All Rights Reserved.